Historique de carrière de Kristie Wagner
Anciens postes connus de Kristie Wagner
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/11/2013 | 01/02/2021 |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Comptroller/Controller/Auditor | 01/06/2021 | - |
| Directeur Financier/CFO | 24/02/2022 | - |
Formation de Kristie Wagner
| Suffolk University | Masters Business Admin |
| Massachusetts College of Liberal Arts | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 1 |
| Masters Business Admin | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Entasis Therapeutics Holdings, Inc.
 Entasis Therapeutics Holdings, Inc. BiotechnologyHealth Technology Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery and development of novel antibacterial products for serious drug-resistant bacterial infections. Its anti-infective discovery platform has produced a pipeline of differentiated programs, which is bacterial infections, including ETX2514SUL (targeting Acinetobacter baumannii infections), ETX0282CPDP (targeting Enterobacteriaceae infections), Non-Beta-lactam PBP inhibitor, and Zoliflodacin. The company was founded in May 2015 and is headquartered in Waltham, MA. | Health Technology |
- Bourse
- Insiders
- Kristie Wagner
- Expérience